If policymakers fail to act swiftly to restore medical research funding, then it’s up to those of us in the industry with the ...

Aaron J. Kowalski, Ph.D., CEO of Breakthrough T1D, spoke with Managed Healthcare Executive, talks about the possible impacts ...

The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.

The National Institutes of Health under President Donald Trump announced this month that it was cutting payments covering ...